Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy

NCT00125437 is registered in ClinicalTrials.gov with Hebei Medical University as lead sponsor.

NCT NCT00125437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00125437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy
Lead sponsor
Hebei Medical University
Phase
Not applicable
Overall status
Terminated
Start date
September 30, 2005
Completion date
September 30, 2009
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, congestive